Hotspots in Neuro-Oncology

Early Activities of Brain Tumour Research in Austria: A Historical Note

REVIEW ARTICLES WHO Guidelines for Diagnosis of Glial Tumours: What Is Old and What Is New? Johan M Kros Technological Advances in Glioma Surgery Lorenzo Bello, et al. Tolerability of Chemotherapy in Elderly Patients Martin Hohenegger Central Nervous System Toxicity of Chemotherapy Uwe Schlegel COLUMNS Education Case Reports Nurses Patient Issues Event Calendar Congress Reports National Reports...

Mapping the future of Neuro-Oncology.

Taking on a successful journal and trying to find ways to improve it is something like adding an agent to an effective chemotherapy regimen: How do you balance the improvements you can attain against the risk of harm you may inadvertently do? As the new editor and co-editor of Neuro-Oncology, we are delighted (and a bit overwhelmed) to have in our hands the premier journal in the field — a jour...

Neuro-oncology and palliative care: a challenging interface.

P atients with high-grade gliomas almost invariably develop disease progression despite recent advances in anticancer therapy. Increasingly, the value of formal palliative care consultation and management has been recognized in both cancer and noncancer medicine. However, there is a paucity of data to definitively guide the provision of palliative care for neuro-oncology patients. This paper ai...

Meeting Update-World Federation of Neuro-Oncology Societies (WFNOS) Meeting 2017.

Neuro-oncology: past milestones and the journey ahead.

Neuro-Oncology will soon reach a new milestone, as Dr. Patrick Wen, Director of the Center for NeuroOncology at Dana-Farber Cancer Institute, assumes the role of editor-in-chief in January 2014. As the journal enters this new era, I find myself reflecting on the milestones it has already reached. The journal has experienced impressive growth and success during its relatively short history, much...